736 related articles for article (PubMed ID: 32249956)
1. Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein.
Hussain M; Jabeen N; Raza F; Shabbir S; Baig AA; Amanullah A; Aziz B
J Med Virol; 2020 Sep; 92(9):1580-1586. PubMed ID: 32249956
[TBL] [Abstract][Full Text] [Related]
2. Structural Modeling of the SARS-CoV-2 Spike/Human ACE2 Complex Interface can Identify High-Affinity Variants Associated with Increased Transmissibility.
Gan HH; Twaddle A; Marchand B; Gunsalus KC
J Mol Biol; 2021 Jul; 433(15):167051. PubMed ID: 33992693
[TBL] [Abstract][Full Text] [Related]
3. Structural genetics of circulating variants affecting the SARS-CoV-2 spike/human ACE2 complex.
Ortuso F; Mercatelli D; Guzzi PH; Giorgi FM
J Biomol Struct Dyn; 2022 Sep; 40(14):6545-6555. PubMed ID: 33583326
[TBL] [Abstract][Full Text] [Related]
4. Evolutionary Arms Race between Virus and Host Drives Genetic Diversity in Bat Severe Acute Respiratory Syndrome-Related Coronavirus Spike Genes.
Guo H; Hu BJ; Yang XL; Zeng LP; Li B; Ouyang S; Shi ZL
J Virol; 2020 Sep; 94(20):. PubMed ID: 32699095
[TBL] [Abstract][Full Text] [Related]
5. Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2.
Suryamohan K; Diwanji D; Stawiski EW; Gupta R; Miersch S; Liu J; Chen C; Jiang YP; Fellouse FA; Sathirapongsasuti JF; Albers PK; Deepak T; Saberianfar R; Ratan A; Washburn G; Mis M; Santhosh D; Somasekar S; Hiranjith GH; Vargas D; Mohan S; Phalke S; Kuriakose B; Antony A; Ustav M; Schuster SC; Sidhu S; Junutula JR; Jura N; Seshagiri S
Commun Biol; 2021 Apr; 4(1):475. PubMed ID: 33846513
[TBL] [Abstract][Full Text] [Related]
6. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
Choudhury A; Mukherjee S
J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration.
Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S
Elife; 2020 Oct; 9():. PubMed ID: 33103998
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 spike protein favors ACE2 from Bovidae and Cricetidae.
Luan J; Jin X; Lu Y; Zhang L
J Med Virol; 2020 Sep; 92(9):1649-1656. PubMed ID: 32239522
[TBL] [Abstract][Full Text] [Related]
9. In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin.
Piplani S; Singh PK; Winkler DA; Petrovsky N
Sci Rep; 2021 Jun; 11(1):13063. PubMed ID: 34168168
[TBL] [Abstract][Full Text] [Related]
10. Molecular dynamic simulation analysis of SARS-CoV-2 spike mutations and evaluation of ACE2 from pets and wild animals for infection risk.
Chen P; Wang J; Xu X; Li Y; Zhu Y; Li X; Li M; Hao P
Comput Biol Chem; 2022 Feb; 96():107613. PubMed ID: 34896769
[TBL] [Abstract][Full Text] [Related]
11. In Silico Investigation of the New UK (B.1.1.7) and South African (501Y.V2) SARS-CoV-2 Variants with a Focus at the ACE2-Spike RBD Interface.
Villoutreix BO; Calvez V; Marcelin AG; Khatib AM
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567580
[TBL] [Abstract][Full Text] [Related]
12. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.
Liu Z; Xiao X; Wei X; Li J; Yang J; Tan H; Zhu J; Zhang Q; Wu J; Liu L
J Med Virol; 2020 Jun; 92(6):595-601. PubMed ID: 32100877
[TBL] [Abstract][Full Text] [Related]
13. Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites.
Williams TL; Strachan G; Macrae RGC; Kuc RE; Nyimanu D; Paterson AL; Sinha S; Maguire JJ; Davenport AP
Sci Rep; 2021 Dec; 11(1):24336. PubMed ID: 34934117
[TBL] [Abstract][Full Text] [Related]
14. Probing structural basis for enhanced binding of SARS-CoV-2 P.1 variant spike protein with the human ACE2 receptor.
Lata S; Akif M
J Cell Biochem; 2022 Jul; 123(7):1207-1221. PubMed ID: 35620980
[TBL] [Abstract][Full Text] [Related]
15. Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
Chakraborty S
Biochem Biophys Res Commun; 2021 Jan; 538():97-103. PubMed ID: 33602511
[TBL] [Abstract][Full Text] [Related]
16. Evolutionary and structural analysis elucidates mutations on SARS-CoV2 spike protein with altered human ACE2 binding affinity.
Chakraborty S
Biochem Biophys Res Commun; 2021 Jan; 534():374-380. PubMed ID: 33272568
[TBL] [Abstract][Full Text] [Related]
17.
Kumar A; Panwar A; Batra K; De S; Maan S
Comb Chem High Throughput Screen; 2021; 24(10):1769-1783. PubMed ID: 33172369
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction.
Brown EEF; Rezaei R; Jamieson TR; Dave J; Martin NT; Singaravelu R; Crupi MJF; Boulton S; Tucker S; Duong J; Poutou J; Pelin A; Yasavoli-Sharahi H; Taha Z; Arulanandam R; Surendran A; Ghahremani M; Austin B; Matar C; Diallo JS; Bell JC; Ilkow CS; Azad T
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668756
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor.
Delgado JM; Duro N; Rogers DM; Tkatchenko A; Pandit SA; Varma S
Proteins; 2021 Sep; 89(9):1134-1144. PubMed ID: 33864655
[TBL] [Abstract][Full Text] [Related]
20. Bioinformatics analysis of the differences in the binding profile of the wild-type and mutants of the SARS-CoV-2 spike protein variants with the ACE2 receptor.
Suleman M; Yousafi Q; Ali J; Ali SS; Hussain Z; Ali S; Waseem M; Iqbal A; Ahmad S; Khan A; Wang Y; Wei DQ
Comput Biol Med; 2021 Nov; 138():104936. PubMed ID: 34655895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
